The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Haralambieva, Iana H ^a   Painter, Scott D ^a   Kennedy, Richard B ^a   Ovsyannikova, Inna G ^a   Lambert, Nathaniel D ^a   Goergen, Krista M ^a   Oberg, Ann L ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CELL MARKER; INFLUENZA VACCINE; MESSENGER RNA; T CELL RECEPTOR REARRANGEMENT EXCISION CIRCLE; T LYMPHOCYTE RECEPTOR; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; TELOMERASE;

ADULT; AGE; AGED; AGING; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSENESCENCE; INFLUENZA VACCINATION; MALE; MEMORY CELL; NORMAL HUMAN; PLASMABLAST; VIRUS NEUTRALIZATION; B LYMPHOCYTE; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; METABOLISM; MIDDLE AGED; T LYMPHOCYTE; TIME FACTOR; VACCINATION; VERY ELDERLY; VIROLOGY;

AGE FACTORS; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOSENESCENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; T-LYMPHOCYTES; TELOMERASE; TIME FACTORS; VACCINATION;

EID: 84929484928     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122282     Document Type: Article

References (65)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186. PMID: 12517228
2. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR RecommRep 2010; 59: 1-62.
3. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 2:1769-1775.
4. Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging 2012; 7: 55-64. doi: 10.2147/CIA.S25215 PMID: 22393283
5. Deans GD, Stiver HG, McElhaney JE. Influenza vaccines provide diminished protection but are costsaving in older adults. J Intern Med 2010; 267:220-227. doi: 10.1111/j.1365-2796.2009.02201.x PMID: 20175868
6. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol 2013; 14: 428-436. doi: 10.1038/ni.2588 PMID: 23598398
7. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75:12182-12187. PMID: 11711609
8. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-5899. PMID: 12023394
9. Targonski PV, Caldwell CR, Strausbauch M, Wettstein P, Poland GA, Tangalos EG. White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza. Clin PharmacolTher 2007; 82: 694-699. PMID: 17971815
10. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: Role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25:3066-3069. PMID: 17275144
11. Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, et al. Effects of aging on influenza virus infection dynamics. J Virol 2014; 88:4123-4131. doi: 10.1128/JVI.03644-13 PMID: 24478442
12. Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, et al. Cross-reactive influenzaspecific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 2013; 190:1837-1848. doi: 10.4049/jimmunol.1201574 PMID: 23319732
13. Halliley JL, Kyu S, Kobie JJ, Walsh EE, Falsey AR, Randall TD, et al. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine 2010; 28: 3582-3587. doi: 10.1016/j.vaccine.2010.02.088 PMID: 20298818
14. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453: 667-671. doi: 10.1038/nature06890 PMID: 18449194
15. Brydak LB, Roszkowska-Blaim M, Machala M, Leszczynska B, Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine 2000; 18:3280-3286. PMID: 10869773
16. Gorse GJ, O'Connor TZ, Newman FK, Mandava MD, Mendelman PM,Wittes J, et al. Immunity to influenza in older adults with chronic obstructive pulmonary disease. J Infect Dis 2004; 190: 11-19. PMID: 15195238
17. McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev 2011; 10: 379-388. doi: 10.1016/j.arr.2010.10.008 PMID: 21055484
18. Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity. J Immunol Methods 2013; 398-399: 44-50.
19. Painter SD, Haralambieva IH, Ovsyannikova IG, Grill DE, Poland GA. Detection of influenza A/H1N1-specific human IgG-secreting B cells in older adults by ELISPOT assay. Viral Immunol 2014; 27: 32-38. doi: 10.1089/vim.2013.0099 PMID: 24605786
20. Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RB, et al. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunol 2012; 25: 29-36. doi: 10.1089/vim.2011. 0051 PMID: 22239234
21. Wang S, Taaffe J, Parker C, Solorzano A, Cao H, Garcia-Sastre A, et al. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J Virol 2006; 80:11628-11637. PMID: 16987975
22. Steel J, Lowen AC, Pena L, Angel M, Solorzano A, Albrecht R, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 2009; 83:1742-1753. doi: 10.1128/JVI.01920-08 PMID: 19073731
23. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of seasonal influenza vaccination in humans. Nat Immunol 2011; 12: 786-795. doi: 10.1038/ni.2067 PMID: 21743478
24. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286: 111-122. PMID: 15087226
25. Rizza SR, Tangalos EG, McClees MD, Strausbauch MA, Targonski PV, McKean DJ, et al. Nelfinavir monotherapy increases naive T-cell numbers in HIV-negative healthy young adults. Front Biosci 2008; 13:1605-1609. PMID: 17981652
26. Zou H, Hastie T. Regularization and variable selection via the elastic net. Journal of the Royal Statistical Society Series B 2005; 67, part 2: 301-320.
27. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw 2010; 33:1-22. PMID: 20808728
28. Linton PJ, Dorshkind K (2004) Age-related changes in lymphocyte development and function. NatImmunol 5: 133-139. PMID: 14749784
29. Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, et al. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 2012; 3:68-90. PMID: 22500272
30. Dorrington MG, Bowdish DM. Immunosenescence and novel vaccination strategies for the elderly. Frontiers Immunol 2013; 4:171. doi: 10.3389/fimmu.2013.00171 PMID: 23825474
31. Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, et al. B cells and aging: molecules andmechanisms. Trends Immunol 2009; 30: 313-318. doi: 10.1016/j.it.2009.04.005 PMID: 19540810
32. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol 2009; 21:418-424. doi: 10.1016/j.coi.2009.05.023 PMID: 19570667
33. Sasaki S, Sullivan M, Narvaez CF, Holmes TH, Furman D, Zheng NY, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccinespecific antibodies. J Clin Invest 2011; 121:3109-3119. doi: 10.1172/JCI57834 PMID: 21785218
34. Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009; 30:351-359. doi: 10.1016/j.it.2009. 05.002 PMID: 19540808
35. Kogut I, Scholz JL, Cancro MP, Cambier JC. B cell maintenance and function in aging. Seminars Immunol 2012; 24:342-349. doi: 10.1016/j.smim.2012.04.004 PMID: 22560930
36. Sambhara S, McElhaney JE. Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 2009; 333:413-429. doi: 10.1007/978-3-540-92165-3-20 PMID: 19768417
37. Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 2011; 108:20012-20017. doi: 10.1073/pnas.1116110108 PMID: 22123971
38. Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, et al. Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci USA 2012; 109: E879-888. doi: 10.1073/pnas.1109797109 PMID: 22434910
39. Frasca D, Riley RL, Blomberg BB. Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin Immunol 2005; 17:378-384. PMID: 15996480
40. Ademokun A, Wu YC, Dunn-Walters D. The ageing B cell population: composition and function. Biogerontology 2010; 11:125-137. doi: 10.1007/s10522-009-9256-9 PMID: 19937382
41. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008; 180:5283-5290. PMID: 18390709
42. McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, hager WD, et al. Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009; 27:2418-2425. doi: 10.1016/j.vaccine.2009.01.136 PMID: 19368783
43. Trzonkowski P, Mysliwska J, Pawelec G, Mysliwski A. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009; 10:83-94. doi: 10.1007/s10522-008-9155-5 PMID: 18563620
44. Reber A, Katz J. Immunological assessment of influenza vaccines and immune correlates of protection. Exp Rev Vaccines 2013; 12:519-536. doi: 10.1586/erv.13.35 PMID: 23659300
45. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 2011; 204:1879-1885. doi: 10.1093/infdis/jir661 PMID: 21998477
46. De Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutinationinhibiting antibody to influenza virus. Dev Biol(Basel) 2003; 115:63-73. PMID: 15088777
47. Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007; 81:215-228. PMID: 17050593
48. Levine M, Beattie BL, McLean DM. Comparison of one-and two-dose regimens of influenza vaccine for elderly men. CMAJ 1987; 137:722-726. PMID: 3651943
49. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-2413. doi: 10.1056/NEJMoa0907413 PMID: 19745216
50. Miraglia JL, Abdala E, Hoff PM, Luiz AM, Oliveira DS, Saad CG, et al. Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. PLos ONE 2011; 6:e27214. doi: 10.1371/journal.pone.0027214 PMID: 22087267
51. Cheong HJ, Song JY, Heo JY, Noh JY, Choi WS, Park DW, et al. Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. Clin Vaccine Immunol 2011; 18:1358-1364. doi: 10.1128/CVI. 05111-11 PMID: 21715575
52. Kurupati RK, Kannan S, Xiang ZQ, Doyle S, Ratcliffe S, Schmader KE, et al. B cell responses to the 2011/12-influenza vaccine in the aged. Aging 2013; 5:209-226. PMID: 23674565
53. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci USA 2012; 109(23):9047-52. doi: 10.1073/pnas.1118979109 PMID: 22615367
54. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181-193. doi: 10.1084/jem.20101352 PMID: 21220454
55. Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013; 5:171ra119.
56. Bernstein E, Kaye D, Abrutyn E, Gross P, Dorfman M, Murasko DM. Immune response to influenza vaccination in a large healthy elderly population. Vaccine 1999; 17:82-94. PMID: 10078611
57. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, et al. Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008; 168: 2405-2414. doi: 10.1001/archinternmed.2008.513 PMID: 19064822
58. Gardner EM, Gonzalez EW, Nogusa S, Murasko DM. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 2006; 24:1609-1614. PMID: 16260072
59. Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplantation 2005; 35:835-857. PMID: 15778723
60. Aspinall R, Pido-Lopez J, Imami N, Henson SM, Ngom PT, Morre M, et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res 2007; 10: 5-17. PMID: 17378748
61. Igarashi H, Sakaguchi N. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 1997; 89:1299-1307. PMID: 9028953
62. Hathcock KS, Kaech SM, Ahmed R, Hodes RJ. Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+ T cells. J Immunol 2003; 170:147-152. PMID: 12496394
63. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009; 30:306-312. doi: 10.1016/j.it.2009.03.013 PMID: 19540809
64. Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ. CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood 2003; 101:3543-3549. PMID: 12506015
65. Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, Vera E, et al. p53 isoforms regulate aging-and tumor-associated replicative senescence in T lymphocytes. J Clin Invest 2013; 123:5247-5257. doi: 10.1172/JCI70355 PMID: 24231352